Hyqvia 30 g (Immunoglobulin (Human) SOLUTION) 30 G

HYQVIA 30 G is a subcutaneous solution containing Immunoglobulin (Human) for immune system support. This product is designed for patients requiring regular immunoglobulin therapy.

Strength

30 G

Manufacturer / TM Owner

TAKEDA CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

HYQVIA 30 G is used to treat immune deficiencies where the body lacks sufficient antibodies. It helps replace missing antibodies to prevent infections. This solution is often used for conditions where the immune system is compromised, providing essential immune support.

Side Effects

Common effects of HYQVIA 30 G may include reactions at the injection site, such as redness or swelling. Some users might experience mild flu-like symptoms, including headache or fatigue. These effects are generally temporary and should be monitored.

Precautions & Warnings

HYQVIA 30 G should be administered under medical supervision. It is important to follow proper handling and storage guidelines to maintain its effectiveness. Patients should inform their healthcare provider about any allergies or medical conditions before use.

Avoid Interactions

HYQVIA 30 G may interact with certain medications, including those that affect the immune system. It is advisable to consult a healthcare provider about potential interactions, especially with other subcutaneous treatments or immune-modulating drugs.

Frequently Asked Questions

HYQVIA 30 G is used to treat immune deficiencies by replacing missing antibodies to help prevent infections.

HYQVIA 30 G is administered subcutaneously, typically under medical supervision.

Common side effects may include reactions at the injection site, such as redness or swelling, and mild flu-like symptoms.

Potential interactions should be discussed with a healthcare provider, especially with other immune-modulating drugs.

HYQVIA 30 G should be stored according to the manufacturer's guidelines to maintain its effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.